Ezrin is required for epithelial-mesenchymal transition induced by TGF-β1 in A549 cells

International Journal of Oncology

Volumn 45, Issue 4, 2014, Pages 1515-1522

  Chen, Miao Juan ^a   Gao, Xue Juan ^a   Xu, Li Na ^a   Liu, Teng Fei ^a   Liu, Xiao Hui ^a   Liu, Lang Xia ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Actin filament reorganization; Cell metastasis; Epithelial mesenchymal transition; Ezrin; Podocalyxin

Indexed keywords

EZRIN; PODOCALYXIN; TRANSFORMING GROWTH FACTOR BETA1; CYTOSKELETON PROTEIN; SIALOGLYCOPROTEIN;

A549 CELL LINE; ACTIN FILAMENT; ARTICLE; CELL INVASION; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; CELL MOTION; GENE EXPRESSION REGULATION; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETAL PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; SIALOGLYCOPROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84907467607     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2554     Document Type: Article

References (48)

1. Lim J and Thiery JP: Epithelial-mesenchymal transitions: insights from development. Development 139: 3471-3486, 2012.
2. Willis BC and Borok Z: TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 293: 525-534, 2007.
3. Savagner P: The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol 21 (Suppl 7): vii89-vii92, doi:10.1093/annonc/mdq292, 2010.
4. Xu J, Lamouille S and Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19: 156-172, 2009.
5. Yilmaz M and Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28: 15-33, 2009.
6. Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890, 2009.
7. Li H, Wang H, Wang F, Gu Q and Xu X: Snail involves in the transforming growth factor β1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells. PLoS One 6: e23322, 2011.
8. Margetts PJ: Twist: a new player in the epithelial-mesenchymal transition of the peritoneal mesothelial cells. Nephrol Dial Transplant 27: 3978-3981, 2012.
9. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654, 2008.
10. Luo W, Fang W, Li S and Yao K: Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma. Int J Cancer 131: 1863-1873, 2012.
11. Pagan R, Sánchez A, Martin I, Llobera M, Fabregat I and Vilaró S: Effects of growth and differentiation factors on the epithelial-mesenchymal transition in cultured neonatal rat hepatocytes. J Hepatol 31: 895-904, 1999. (Pubitemid 29514224)
12. Saitoh M and Miyazawa K: Transcirptional and post-transcriptional regulation in TGF-β-mediated epithelial-mesenchymal transition. J Biochem 151: 563-571, 2012.
13. American Thoracic Society, European Respiration Society: American Thoracic Society/European Respiration Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165: 277-304, 2002.
14. Selman M and Pardo A: Alveolar epithelial cell disintegrity and subsequent activation: a key process in pulmonary fibrosis. Am J Respir Crit Care Med 186: 119-121, 2012.
15. Marmai C, Sutheriand RE, Kim KK, et al: Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 301: L71-L78, 2011.
16. Kolosova I, Nethery D and Kern JA: Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells. J Cell Physiol 226: 1248-1254, 2011.
17. Tsukita S and Yonemura S: Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins. J Biol Chem 274: 34507-34510, 1999. (Pubitemid 129509480)
18. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A and Tsukita S: ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126: 391-401, 1994. (Pubitemid 24226255)
19. Buckley ST, Medina C, Kasper M and Ehrhardt C: Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 300: L548-L559, 2011.
20. Ehrhardt C, Medina C and Buckley ST: Interaction of RAGE with focal adhesion molecules during alveolar epithelial-mesenchymal transition. FASEB J 25: 865, 2011.
21. Haynes J, Srivastava J, Madson N, Wittmann T and Barber DL: Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression. Mol Biol Cell 22: 4750-4764, 2011.
22. Nielsen JS and McNagny KM: The role of podocalyxin in health and disease. J Am Soc Nephrol 20: 1669-1676, 2009.
23. Orlando RA, Takeda T, Zak B, et al: The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interaction with ezrin. J Am Soc Nephrol 12: 1589-1598, 2001. (Pubitemid 32674420)
24. Li Y, Li J, Straight SW and Kershaw DB: PDZ domain-mediated interaction of rabbit podocalyxin and Na(+)/H(+) exchange regulatory factor-2. Am J Physiol Renal Physiol 282: 1129-1139, 2002.
25. Sizemore S, Cicek M, Sizemore N, Ng KP and Casey G: Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Cancer Res 67: 6183-6191, 2007. (Pubitemid 47037499)
26. Meng X, Ezzati P and Wilkins JA: Requirement of podocalyxin in TGF-beta induced epithelial mesenchymal transition. PLoS One 6: e18715, 2011.
27. Ohtani K, Sakamoto H, Rutherford T, Chen Z, Satoh K and Naftolin F: Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Cancer Lett 147: 31-38, 1999.
28. Elliott BE, Meens JA, SenGupta SK, Louvard D and Arpin M: The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res 7: R365-R373, 2005.
29. Osawa H, Smith CA, Ra YS, Kongkham P and Rutka JT: The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells. Neuro Oncol 11: 381-393, 2009.
30. Cant SH and Pitcher JA: G protein-coupled receptor kinase 2-mediated phosphorylation of ezrin is required for G proteincoupled receptor-dependent reorganization of the actin cytoskeleton. Mol Biol Cell 16: 3088-3099, 2005. (Pubitemid 40962582)
31. Crepaldi T, Gautreau A, Comoglio PM, Louvard D and Arpin M: Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J Cell Biol 138: 423-434, 1997. (Pubitemid 27323543)
32. Huang HY, Li CF, Fang FM, Tsai JW, Li SH, Lee YT and Wei HM: Prognostic implication of ezrin overexpression in myxofibrosarcomas. Ann Surg Oncol 17: 3212-3219, 2010.
33. Li Q, Gao H, Xu H, et al: Expression of ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells. Tumour Biol 33: 1493-1504, 2012.
34. Sarrió D, Rodríguez-Pinilla SM, Dotor A, Calero F, Hardisson D and Palacios J: Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas. Breast Cancer Res Treat 98: 71-79, 2006. (Pubitemid 44050782)
35. Pérez P, Aguilera S, Olea N, et al: Aberrant localization of ezrin correlates with salivary acini disorganization in Sjögren's Syndrome. Rheumatology 49: 915-923, 2010.
36. Arslan AA, Silvera D, Arju R, Giashuddin S, Belitskaya-Levy I, Formenti SC and Schneider RJ: Atypical ezrin localization as a marker of locally advanced breast cancer. Breast Cancer Res Treat 134: 981-988, 2012.
37. Berryman M, Franck Z and Bretscher A: Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 105: 1025-1043, 1993. (Pubitemid 23258665)
38. Bretscher A, Edwards K and Fehon RG: ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3: 586-599, 2002.
39. Moilanen J, Lassus H, Leminen A, Vaheri A, Bützow R and Carpén O: Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients. Gynecol Oncol 90: 273-281, 2003. (Pubitemid 36952014)
40. Tokunou M, Niki T, Saitoh Y, Imamura H, Sakamoto M and Hirohashi S: Altered expression of the ERM proteins in lung adenocarcinoma. Lab Invest 80: 1643-1650, 2000.
41. Gautreau A, Louvard D and Arpin M: Morphogenic effects of ezrin require a phosphorylation-induced transition from oligomers to monomers at the plasma membrane. J Cell Biol 150: 193-203, 2000. (Pubitemid 30480237)
42. Bretscher A: Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor. J Cell Biol 108: 921-930, 1989.
43. Jiang WG, Hiscox S, Singhrao SK, Puntis MC, Nakamura T, Mansel RE and Hallett MB: Induction of tyrosine phosphorylation and translocation of ezrin by hepatocyte growth factor/scatter factor. Biochem Biophys Res Commun 217: 1062-1069, 1995. (Pubitemid 26019760)
44. Chen Z, Fadiel A, Feng Y, Ohtani K, Rutherford T and Naftolin F: Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor. Cancer 92: 3068-3075, 2001. (Pubitemid 33136203)
45. Martin TA, Harrison G, Mansel RE and Jiang WG: The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol 46: 165-186, 2003. (Pubitemid 36452345)
46. Weinman EJ, Steplock D, Donowitz M and Shenolikar S: NHERF associations with sodium-hydrogen exchanger isoform 3 (NHE3) and ezrin are essential for cAMP-mediated phosphorylation and inhibition of NHE3. Biochemistry 39: 6123-6129, 2000. (Pubitemid 30327087)
47. Heiska L, Alfthan K, Grönholm M, Vilja P, Vaheri A and Carpén O: Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4, 5-bisphosphate. J Biol Chem 273: 21893-21900, 1998. (Pubitemid 28405367)
48. Schmieder S, Nagai M, Oriando RA, Takeda T and Farquhar MG: Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and ezrin in MDCK cells. J Am Soc Nephrol 15: 2289-2298, 2004. (Pubitemid 39159329)